Cargando…
The Effects of Glucose-Lowering Therapies on Diabetic Kidney Disease
Chronic hyperglycemia and its associated metabolic products are key factors responsible for the development and progression of diabetic chronic kidney disease (CKD). Endocrinologists are tasked with detection and management of early CKD before patients need referral to a nephrologist for advanced CK...
Autores principales: | Agrawal, V., Giri, C., Solomon, R. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398087/ https://www.ncbi.nlm.nih.gov/pubmed/25824237 http://dx.doi.org/10.2174/1573399811666150331160534 |
Ejemplares similares
-
Progression of glucose‐lowering diabetes therapy in TECOS
por: Bethel, M. Angelyn, et al.
Publicado: (2018) -
Hemorheological Parameters in Diabetic Patients: Role of Glucose Lowering Therapies
por: Biro, Katalin, et al.
Publicado: (2021) -
Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis
por: Reaven, Peter D., et al.
Publicado: (2009) -
Cardiac gene therapy treats diabetic cardiomyopathy and lowers blood glucose
por: Li, Jing, et al.
Publicado: (2023) -
Renal and Glucose-Lowering Effects of Empagliflozin and Dapagliflozin in Different Chronic Kidney Disease Stages
por: Lin, Yi-Hsuan, et al.
Publicado: (2019)